Bovie Medical Reveals That J-Plasma Performs Well In All Surgeries

Trade BVX now with

7/10/2012 7:53 AM ET

Bovie Medical Corporation (BVX: Quote) Tuesday announced that its product J-Plasma has been performing well in both laparoscopic surgeries as well as open surgeries.

The company, engaged in the manufacture and marketing of electrosurgical products, stated that in multiple patient procedures, there was a decrease in smoke, less charring and overall excellent tissue response when compared to current electrosurgery devices.

Jeff Rencher, Vice President of Sales and Marketing of Surgical Products stated, "The positive results achieved by J-Plasma met all expectations as we prepare to embark on an aggressive marketing program for the product."

Click here to receive FREE breaking news email alerts for Bovie Medical Corp and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

<<Previous 325 Articles

Editors Pick

Fed Concerns Contribute To Lackluster Session On Wall Street - U.S. Commentary

There was a mixed performance on Wall Street on Friday. Shares suffered an early decline, as investors continued to express worries about the Federal Reserve. A recovery through the rest of the day allowed the Dow to edge into positive territory by the close. The Nasdaq and S&P 500 posted fractional losses.

Stocks Come Under Pressure Amid Worries About The Fed - U.S. Commentary

Stocks have shown a notable move to the downside in early trading on Friday amid lingering concerns about the outlook for the Federal Reserve's asset purchase program. The major averages have slid firmly into negative territory, adding to the modest losses posted in the previous session. The major averages are currently posting notable losses, near their lows for the young session.

U.S. Durable Goods Orders Rise 3.3% In April, More Than Expected

After reporting a sharp drop in new orders for manufactured durable goods in the previous month, the Commerce Department released a report on Friday showing that durable goods orders rebounded by more than anticipated in the month of April. The report said durable goods orders surged up by 3.3 percent in April after tumbling by a revised 5.9 percent in March.

Bovie Medical Reveals That J-Plasma Performs Well In All Surgeries

FDA Panel Backs Merck Insomnia Drug Suvorexant, But At Lower Doses

WSJ: Fidelity National, Thomas H Lee In Talks To Buy Lender Processing Services

Goodman Networks, Multiband To Merge In $116 Mln Cash Deal - Quick Facts

NetApp Profit Tops Estimates; Boosts Buyback; Initiates Dividend

G4S Plc Names Ashley Almanza CEO; Eddie Aston Named New COO

Philip Morris To Buy Remaining 20% Stake In Mexican Unit For About $700 Mln

Bloomberg: Fannie Mae To Sell $2 Bln Of CMBS

Zee Entertainment Q4 Stand-Alone Profit Up

Biogen Idec Submits BLA To FDA For Approval Of Plegridy In Multiple Sclerosis

Workday Q1 Loss Widens; Lifts FY14 Revenue Outlook - Quick Facts

Invensys To Return About GBP 625 Mln Cash To Shareholders - Quick Facts

WSJ: Fidelity National, Thomas H Lee In Talks To Buy Lender Processing Services

EveryWare Global, ROI Acquisition Complete Business Combination

FDA Panel Backs Merck Insomnia Drug Suvorexant, But At Lower Doses

MRPL Posts Q4 Loss On Higher Costs

G4S Plc Names Ashley Almanza CEO; Eddie Aston Named New COO

Zytronic H1 Pretax Profit Decreases - Quick Facts

Biogen Idec Submits BLA To FDA For Approval Of Plegridy In Multiple Sclerosis

Bloomberg: Fannie Mae To Sell $2 Bln Of CMBS

Cinemark USA Announces Pricing Of $530 Mln Of 4.875% Senior Notes Due 2023